β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study

Abstract

The authors found that exposure to β-blockers during pregnancy was associated with being born SGA, preterm birth and perinatal mortality. Our findings show that labetalol is not safer than other β-blockers during pregnancy.